Skip to content
Geographic · Total revenues

Geographic — Total revenues

Amgen Geographic — Total revenues remained flat by 0.0% to $2.58B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $2.39B to $2.58B. Over 4 years (FY 2021 to FY 2025), Geographic — Total revenues shows an upward trend with a 7.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025Feb 13, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful international market expansion or higher demand for products in global markets, while a decrease may signal competitive pressure or regulatory hurdles abroad.

Detailed definition

This metric represents the total gross revenue generated by the company from operations outside of its primary domestic...

Peer comparison

Comparable to 'International Revenue' or 'Non-US Revenue' reported by other multinational pharmaceutical and biotechnology firms.

Metric ID: amgn_segment_row_total_revenues

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$7.79B$7.73B$8.38B$9.56B$10.33B
YoY Change-0.7%+8.5%+14.0%+8.1%
Range$7.73B$10.33B
CAGR+7.3%
Avg YoY Growth+7.5%
Median YoY Growth+8.3%
Current Streak3 years growth

Frequently Asked Questions

What is Amgen's geographic — total revenues?
Amgen (AMGN) reported geographic — total revenues of $2.58B in Q4 2025.
How has Amgen's geographic — total revenues changed year-over-year?
Amgen's geographic — total revenues increased by 8.1% year-over-year, from $2.39B to $2.58B.
What is the long-term trend for Amgen's geographic — total revenues?
Over 4 years (2021 to 2025), Amgen's geographic — total revenues has grown at a 7.3% compound annual growth rate (CAGR), from $7.79B to $10.33B.
What does geographic — total revenues mean?
The total sales revenue generated by the company from all geographic regions outside its home country.